1345731-62-5 Usage
Description
(4-Chlorophenyl)((3R,5S)-7-(difluoromethoxy)-3,5-dimethyl-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)methanone is a benzoxazepine derivative, a white solid with a molecular formula of C19H16ClF2NO3 and a molecular weight of 377.78 g/mol. It has potential pharmaceutical applications, particularly in the field of neuroscience and central nervous system disorders.
Uses
Used in Pharmaceutical Industry:
(4-Chlorophenyl)((3R,5S)-7-(difluoromethoxy)-3,5-dimethyl-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)methanone is used as a potential therapeutic agent for central nervous system disorders due to its pharmacological properties and ongoing research in the field of neuroscience.
Used in Research and Development:
(4-Chlorophenyl)((3R,5S)-7-(difluoromethoxy)-3,5-dimethyl-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)methanone is used as a subject of study in research and development for its potential applications in treating various central nervous system-related conditions, as further studies are being conducted to explore its pharmacological properties and therapeutic uses.
Check Digit Verification of cas no
The CAS Registry Mumber 1345731-62-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,5,7,3 and 1 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1345731-62:
(9*1)+(8*3)+(7*4)+(6*5)+(5*7)+(4*3)+(3*1)+(2*6)+(1*2)=155
155 % 10 = 5
So 1345731-62-5 is a valid CAS Registry Number.
1345731-62-5Relevant articles and documents
Discovery of potent selective orally active benzoxazepine-based orexin-2 receptor antagonists
Fujimoto, Tatsuhiko,Kunitomo, Jun,Tomata, Yoshihide,Marui, Shogo,Nishiyama, Keiji,Nakashima, Masato,Yoshikubo, Shin-Ichi,Hirai, Keisuke,Hirozane, Mariko
supporting information; experimental part, p. 6414 - 6416 (2011/11/29)
During our efforts to identify a series of potent, selective, orally active human Orexin-2 Receptor (OX2R) antagonists, we elucidated structure-activity relationship (SAR) on the 7-position of a benzoxazepine scaffold by utilizing Hammett rp and Hansch-Fu
